AC Immune SA
Quick facts
Phase 2 pipeline
- ACI-7104.056 at Dose A · Neurology
ACI-7104.056 is a tau aggregation inhibitor.
Phase 1 pipeline
- ACI-19764 at dose A1
- ACI-19764 at dose A2
- ACI-19764 at dose A3
- ACI-19764 at dose A4
- ACI-19764 at dose A5
- ACI-19764 at dose A6
- ACI-19764 at dose B1
- ACI-19764 at dose B2
- ACI-19764 at dose B3
- ACI-24.060 at Dose A
- ACI-24.060 at Dose B
- ACI-24.060 at Dose C
- ACI-24.060 at Dose D
- ACI-24 high dose
- ACI-24 low dose
- ACI-35.030
- JACI-35.054
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: